Subscribe
silver-wings-ss
Silver Wings SS / Shutterstock.com
16 April 2020MedtechRory O'Neill

UK govt backs ventilator makers against potential IP complaints

The UK government will indemnify ventilator manufacturers from the financial burden arising from any potential IP breaches, as health services around the world scramble to up their capacity of the devices.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Compulsory licensing in Canada—revisited
21 April 2020   New legislation has been enacted to help in the efforts to deal with the COVID-19 outbreak, as Daphne Lainson and Nancy Pei of Smart & Biggar report.
Big Pharma
Canada authorises compulsory licences for COVID-19 shortfalls
27 March 2020   Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.
Europe
Ventilator maker offers up IP to tackle shortage
23 March 2020   UK engineering company Smiths Group is making the IP covering one of its ventilators available to other manufacturers, as part of an industry attempt to tackle the shortage of life-saving equipment.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Big Pharma
Canada authorises compulsory licences for COVID-19 shortfalls
27 March 2020   Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.
Europe
Ventilator maker offers up IP to tackle shortage
23 March 2020   UK engineering company Smiths Group is making the IP covering one of its ventilators available to other manufacturers, as part of an industry attempt to tackle the shortage of life-saving equipment.
Big Pharma
Compulsory licensing in Canada—revisited
21 April 2020   New legislation has been enacted to help in the efforts to deal with the COVID-19 outbreak, as Daphne Lainson and Nancy Pei of Smart & Biggar report.

More on this story

Big Pharma
Canada authorises compulsory licences for COVID-19 shortfalls
27 March 2020   Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.
Europe
Ventilator maker offers up IP to tackle shortage
23 March 2020   UK engineering company Smiths Group is making the IP covering one of its ventilators available to other manufacturers, as part of an industry attempt to tackle the shortage of life-saving equipment.
Big Pharma
Compulsory licensing in Canada—revisited
21 April 2020   New legislation has been enacted to help in the efforts to deal with the COVID-19 outbreak, as Daphne Lainson and Nancy Pei of Smart & Biggar report.

More features

Novartis shields eye-drop patent at European Patent Office
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages
Judge denies Intellia bid to throw out suit over $100m Regeneron pact